AMENDMENT NO. 3 Dated as of December 20, 2018 to SECOND AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT Dated as of January 17, 2013

Exhibit 2.30

EXECUTION VERSION

AMENDMENT NO. 3

Dated as of December 20, 2018

SECOND AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT

Dated as of January 17, 2013

THIS AMENDMENT No. 3 (this “Amendment”) dated as of December 20, 2018 is entered into by and between NMC FUNDING CORPORATION, a Delaware corporation, as Purchaser (the “Purchaser”) and NATIONAL MEDICAL CARE, INC., a Delaware corporation, as Seller (the “Seller”).

PRELIMINARY STATEMENTS

A. The Purchaser and the Seller are parties to that certain Second Amended and Restated Receivables Purchase Agreement dated as of January 17, 2013 (as amended or otherwise modified prior to the date hereof, the “RPA”). Capitalized terms used herein and not otherwise defined shall have the meanings ascribed to them in the RPA.

B. The Purchaser and the Seller have agreed to amend the RPA on the terms and conditions hereinafter set forth.

NOW, THEREFORE, in consideration of the premises set forth above, and other good and valuable consideration the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:

SECTION 1. Amendments.

1.1 Section 2.7 of the RPA is hereby amended by replacing such section in its entirety with the following:

Section 2.7 Addition and Removal of Transferring Affiliates. (a) If (i) one or more direct or indirect wholly-owned Subsidiaries of the FMCH (other than the Transferring Affiliates) now owned or hereafter acquired, is primarily engaged in the same business as is conducted on the date hereof by FMCH and the Transferring Affiliates or (ii) FMCH reorganizes its corporate structure such that facilities generating Receivables on the date hereof (or acquired as contemplated by clause (i)) are owned by one or more additional direct or indirect wholly-owned Subsidiaries of the FMCH, any or all of the wholly-owned subsidiaries referred to in clauses (i) and (ii) may, with the prior written consent of the Purchaser and the Agent (which consent shall not be unreasonably withheld or delayed), become Transferring Affiliates under this Agreement upon delivery to the Purchaser and the Agent of (x) counterparts of the Transferring Affiliate Letter duly executed by such

subsidiary or subsidiaries and (y) the documents relating to such subsidiary or subsidiaries of the kind delivered by or on behalf of the Transferring Affiliates pursuant to Section 4.1, together with such other instruments, documents and agreements as either the Purchaser or the Agent may reasonably request in connection therewith.

(b) If any existing Transferring Affiliate wishes to be removed as a party to the Transferring Affiliate Letter, such existing Transferring Affiliate shall be removed as a Transferring Affiliate under this Agreement simultaneously with, and subject to the satisfaction of the conditions required for, its removal as a Transferring Affiliate under the Transferring Affiliate Letter and the TAA pursuant to Section 2.15 of the TAA.

(c) Upon the addition or removal of any Transferring Affiliate pursuant to subsection (a) or (b) above, as applicable, the provisions of this Agreement, including Exhibit J, shall, without further act or documentation, be deemed amended, and in the case of any such Subsidiary being added as a Transferring Affiliate, to apply to any such entity to the same extent as the same apply to the Transferring Affiliates as of the date hereof and the term “Transferring Affiliate” in this Agreement shall mean and refer to such entity as well as each then existing Transferring Affiliate.

1.2 Exhibit F (List of Actions and Suits) of the RPA is hereby deleted and replaced with the new Exhibit F attached hereto as Exhibit 1.

1.3 Exhibit G (Location of Records) of the RPA is hereby deleted and replaced with the new Exhibit G attached hereto as Exhibit 2.

1.4 Exhibit H (List of Seller’s Subsidiaries, Divisions and Tradenames) of the RPA is hereby deleted and replaced with the new Exhibit H attached hereto as Exhibit 3.

1.5 Exhibit I (Form of Transferring Affiliate Letter) of the RPA is hereby amended to insert at the end of such exhibit the form of Amendment No. 7 to the Transferring Affiliate Letter attached hereto as Exhibit 4.

1.6 Exhibit J (List of Transferring Affiliates, Chief Executive Offices of Transferring Affiliates and Tradenames) of the RPA is hereby deleted and replaced with the new Exhibit J attached hereto as Exhibit 5.

SECTION 2. Conditions Precedent. This Amendment shall become effective and be deemed effective as of the date hereof upon (i) the receipt by the Purchaser of counterparts of this Amendment duly executed by the Purchaser and the Seller, (ii) the effectiveness of Amendment No. 7 to the Amended and Restated Transferring Affiliate Letter of even date herewith among the Seller and each Transferring Affiliate and (iii) the effectiveness of

Amendment No. 2 to the Seventh Amended and Restated Transfer and Administration Agreement of even date herewith among the Seller, the Purchaser, the Transferor, the Collection Agent, the Administrative Agents and the Agent.

SECTION 3. Covenants, Representations and Warranties of the Seller.

3.1 Upon the effectiveness of this Amendment, the Seller hereby reaffirms all covenants, representations and warranties made by it in the RPA and agrees that all such covenants, representations and warranties shall be deemed to have been remade as of the effective date of this Amendment.

3.2 The Seller hereby represents and warrants that (i) this Amendment constitutes the legal, valid and binding obligation of such party, enforceable against it in accordance with its terms and (ii) upon the effectiveness of this Amendment, no Seller Default or Potential Seller Default shall exist under the RPA.

SECTION 4. Reference to and Effect on the RPA.

4.1 Upon the effectiveness of this Amendment, each reference in the RPA to “this Agreement,” “hereunder,” “hereof,” “herein,” “hereby” or words of like import shall mean and be a reference to the RPA as amended hereby, and each reference to the RPA in any other document, instrument and agreement executed and/or delivered in connection with the RPA shall mean and be a reference to the RPA as amended hereby.

4.2 Except as specifically amended hereby, the RPA and all other documents, instruments and agreements executed and/or delivered in connection therewith shall remain in full force and effect and are hereby ratified and confirmed.

4.3 The execution, delivery and effectiveness of this Amendment shall not operate as a waiver of any right, power or remedy of the Purchaser or any of its assignees under the RPA or any other document, instrument, or agreement executed in connection therewith, nor constitute a waiver of any provision contained therein.

SECTION 5. Governing Law. THIS AMENDMENT SHALL BE GOVERNED AND CONSTRUED IN ACCORDANCE WITH THE INTERNAL LAWS (AS OPPOSED TO THE CONFLICT OF LAW PROVISIONS) AND DECISIONS OF THE STATE OF NEW YORK.

SECTION 6. Execution in Counterparts. This Amendment may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so executed and delivered shall be deemed to be an original and all of which taken together shall constitute but one and the same instrument. Delivery of an executed counterpart via facsimile or other electronic transmission shall be deemed delivery of an original counterpart.

SECTION 7. Headings. Section headings in this Amendment are included herein for convenience of reference only and shall not constitute a part of this Amendment for any other purpose.

[The remainder of this page intentionally left blank]

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed by their respective officers thereunto duly authorized as of the date first written above.

	NMC FUNDING CORPORATION,
	as Purchaser

	By:	/s/ Xxxx Xxxxxxx
	Name:	Xxxx Xxxxxxx
	Title:	Senior Vice President & Treasurer

	NATIONAL MEDICAL CARE, INC.,
	as Seller

	By:	/s/ Xxxx Xxxxxxx
	Name:	Xxxx Xxxxxxx
	Title:	Senior Vice President & Treasurer

Signature Page

Amendment No. 3 to Second Amended and Restated Receivables Purchase Agreement

Exhibit 1

to Amendment

EXHIBIT F

SECOND AMENDED AND RESTATED

RECEIVABLES PURCHASE AGREEMENT

LIST OF ACTIONS AND SUITS

SECTION 3.1(g)

3.1(g)(i) Transferor: None

3.1(g)(ii) Affiliates: The “Legal and Regulatory Matters” section of the most recent annual report on Form 20-F or report on Form 6-K for the quarter, as applicable, and such other Form 6-Ks referencing therein any actions, suits or proceedings, each as filed by Fresenius Medical Care AG & Co. KGaA (“FME KGaA” or the “Company”) with the U.S. Securities and Exchange Commission (“SEC”) under the Securities Exchange Act of 1934 is hereby incorporated by reference as if fully set forth herein.

Such filings can be found on the SEC website at the following link: xxxxx://xxx.xxx.xxx/xxx-xxx/xxxxxx-xxxxx?xxxxxxxxxxxxxxxxx&XXXx0000000000&xxxxxxxxxxxxx&xxxxxx00&xxxxxxxxxxxx0

The following are excerpts from the report on Form 6-K of FME KGaA filed with the Securities and Exchange Commission on October 30, 2018 for the period ending September 30, 2018 (in thousands, except share and per share data):

Legal and Regulatory Matters

The Company is routinely involved in claims, lawsuits, regulatory and tax audits, investigations and other legal matters arising, for the most part, in the ordinary course of its business of providing health care services and products. Legal matters that the Company currently deems to be material or noteworthy are described below. For the matters described below in which the Company believes a loss is both reasonably possible and estimable, an estimate of the loss or range of loss exposure is provided. For the other matters described below, the Company believes that the loss probability is remote and/or the loss or range of possible losses cannot be reasonably estimated at this time. The outcome of litigation and other legal matters is always difficult to predict accurately and outcomes that are not consistent with the Company’s view of the merits can occur. The Company believes that it has valid defenses to the legal matters pending against it and is defending itself vigorously. Nevertheless, it is possible that the resolution of one or more of the legal matters currently pending or threatened could have a material adverse effect on its business, results of operations and financial condition.

On February 15, 2011, a whistleblower (relator) action under the False Claims Act against FMCH was unsealed by order of the United States District Court for the District of Massachusetts and served by the relator. United States ex rel. Xxxxx Xxxxxxx v. Fresenius Medical Care Holdings, Inc., 2009 Civ. 10179 (D. Mass.). The relator’s complaint, which was first filed under seal in February 2009, alleged that FMCH sought and received reimbursement from government payors for serum ferritin and multiple forms of

hepatitis B laboratory tests that were medically unnecessary or not properly ordered by a physician. Discovery on the relator’s complaint closed in May 2015. Although the United States initially declined to intervene in the case, the government subsequently changed position. On April 3, 2017, the court allowed the government to intervene with respect only to certain hepatitis B surface antigen tests performed prior to 2011, when Medicare reimbursement rules for such tests changed. The court has subsequently rejected government requests to conduct new discovery and to add counts to its complaint-in-intervention that would expand upon the relator’s complaint, but has allowed FMCH to take discovery against the government as if the government had intervened at the outset.

Beginning in 2012, the Company received certain communications alleging conduct in countries outside the U.S. that might violate the Foreign Corrupt Practices Act (“FCPA”) or other anti-bribery laws. Since that time, the Company’s Supervisory Board, through its Audit and Corporate Governance Committee, has conducted investigations with the assistance of independent counsel. In a continuing dialogue, the Company voluntarily advised the Securities and Exchange Commission (“SEC”) and the U.S. Department of Justice (“DOJ”) about these investigations, while the SEC and DOJ (collectively the “government” or “government agencies”) have conducted their own investigations, in which the Company has cooperated.

In the course of this dialogue, the Company identified and reported to the government, and has taken remedial actions including employee disciplinary actions with respect to, conduct that has resulted in the government agencies’ seeking monetary penalties or other sanctions against the Company under the FCPA or other anti-bribery laws. Such conduct or its remediation may impact adversely the Company’s ability to conduct business in certain jurisdictions.

The Company has substantially concluded its investigations and undertaken discussions toward a possible settlement with the government agencies that would avoid litigation over government demands related to certain identified conduct. These discussions are continuing and have not yet achieved an agreement; failure to reach agreement and consequent litigation with either or both government agencies remains possible. The discussions have revolved around possible bribery and corruption questions principally related to certain conduct in the Company’s products business in a number of countries.

The Company recorded a charge of €200,000 in the fourth quarter of 2017. The charge encompassed an estimate of the government agencies claims for profit disgorgement, as well as accruals for fines or penalties, certain legal expenses and other related costs or asset impairments. The Company increased the provision by €75,000 to reflect an understanding with the government agencies on the financial aspects of a potential settlement and an update of legal costs to continue with these discussions. Following this increase, which takes into account incurred and anticipated legal expenses, impairments and other costs, the provision totals €243,000 as of September 30, 2018. However, significant non-financial matters are still under discussion with the government and must be resolved to the Company’s satisfaction for a settlement to occur.

The Company continues to implement enhancements to its anti-corruption compliance program, including internal controls related to compliance with international anti-bribery laws. The Company continues to be fully committed to FCPA and other anti-bribery law compliance.

Personal injury litigation involving the Company’s acid concentrate product, labeled as Granuflo® or Naturalyte®, first arose in 2012 and was substantially resolved by settlement agreed in principle in February 2016 and consummated in November 2017, as previously disclosed. Remaining individual personal injury cases do not present material risk and discussion of them is therefore discontinued.

The Company’s affected insurers agreed to the settlement of the acid concentrate personal injury litigation and funded $220,000 of the settlement fund under a reciprocal reservation of rights encompassing certain

F-2

coverage issues raised by insurers and the Company’s claims for indemnification of defense costs. The Company accrued a net expense of $60,000 in connection with the settlement, including legal fees and other anticipated costs.

Following entry into the settlement, the Company’s insurers in the AIG group and the Company each initiated litigation against the other relating to the AIG group’s coverage obligations under applicable policies. In the coverage litigation, the AIG group seeks to be indemnified by the Company for a portion of its $220,000 outlay; the Company seeks to confirm the AIG group’s $220,000 funding obligation, to recover defense costs already incurred by the Company, and to compel the AIG group to honor defense and indemnification obligations, if any, required for resolution of cases not participating in the settlement. As a result of decisions on issues of venue, the coverage litigation is proceeding in the New York state trial court for Manhattan. (National Union Fire Insurance v. Fresenius Medical Care, 2016 Index No. 653108 (Supreme Court of New York for New York County)).

Four institutional plaintiffs filed complaints against FMCH or its affiliates under state deceptive practices statutes resting on certain background allegations common to the GranuFlo®/NaturaLyte® personal injury litigation, but seeking as remedy the repayment of sums paid to FMCH attributable to the GranuFlo®/NaturaLyte® products. These cases implicate different legal standards, theories of liability and forms of potential recovery from those in the personal injury litigation and their claims were not extinguished by the personal injury litigation settlement described above. The four plaintiffs are the Attorneys General for the States of Kentucky, Louisiana and Mississippi and the commercial insurance company Blue Cross Blue Shield of Louisiana in its private capacity. State of Mississippi ex rel. Hood, v. Fresenius Medical Care Holdings, Inc., No. 14-cv-152 (Chancery Court, DeSoto County); State of Louisiana ex re. Xxxxxxxx and Louisiana Health Service & Indemnity Company v. Fresenius Medical Care Airline, 2016 Civ. 11035 (U.S.D.C. D. Mass.); Commonwealth of Kentucky ex rel. Beshear v. Fresenius Medical Care Holdings, Inc. et al., No. 00-XX-00000 (Xxxxxxx Xxxxx, Xxxxxxxx Xxxxxx). A jury trial has been scheduled to begin in the Kentucky (Beshear) case on January 22, 2019.

The Company is not a party to a substantial adverse jury verdict and punitive damage award entered in Denver on June 27, 2018 against DaVita Healthcare Partners, Inc. (“DaVita”), involving DaVita’s own clinical management of the Company’s acid concentrate product. See, White v. DaVita Healthcare Partners, Inc., 2015 Civ. 02106 (U.S.D.C. Colorado).

In August 2014, FMCH received a subpoena from the United States Attorney for the District of Maryland inquiring into FMCH’s contractual arrangements with hospitals and physicians involving contracts relating to the management of in-patient acute dialysis services. FMCH is cooperating in the investigation.

In July 2015, the Attorney General for Hawaii issued a civil complaint under the Hawaii False Claims Act alleging a conspiracy pursuant to which certain Liberty Dialysis subsidiaries of FMCH overbilled Hawaii Medicaid for Liberty’s Epogen® administrations to Hawaii Medicaid patients during the period from 2006 through 2010, prior to the time of FMCH’s acquisition of Liberty. Hawaii v. Liberty Dialysis — Hawaii, LLC et al., Case No. 15-1-1357-07 (Hawaii 1st Circuit). The State alleges that Liberty acted unlawfully by relying on incorrect and unauthorized billing guidance provided to Liberty by Xerox State Healthcare LLC, which acted as Hawaii’s contracted administrator for its Medicaid program reimbursement operations during the relevant period. The amount of the overpayment claimed by the State is approximately $8,000, but the State seeks civil remedies, interest, fines, and penalties against Liberty and FMCH under the Hawaii False Claims Act substantially in excess of the overpayment. After prevailing on motions by Xerox to preclude it from doing so, FMCH is pursuing third-party claims for contribution and indemnification against Xerox. The State’s False Claims Act complaint was filed after Liberty initiated an administrative action challenging the State’s recoupment of alleged overpayments

F-3

from sums currently owed to Liberty. The civil litigation and administrative action are proceeding in parallel. Trial in the civil litigation is scheduled for April 2019.

On August 31 and November 25, 2015, respectively, FMCH received subpoenas under the False Claims Act from the United States Attorneys for the District of Colorado and the Eastern District of New York inquiring into FMCH’s participation in and management of dialysis facility joint ventures in which physicians are partners. On March 20, 2017, FMCH received a subpoena in the Western District of Tennessee inquiring into certain of the operations of dialysis facility joint ventures with the University of Tennessee Medical Group, including joint ventures in which FMCH’s interests were divested to Satellite Dialysis in connection with FMCH’s acquisition of Liberty Dialysis in 2012. FMCH has cooperated in these investigations.

On September 26, 2018, the US Attorney for the Eastern District of New York declined to intervene on the qui tam complaint filed under seal in 2014 that gave rise to this investigation. CKD Project LLC v. Fresenius Medical Care, 2014 Civ. 6646 (E.D.N.Y. November 12, 2014). The court then unsealed the complaint, allowing the relator to serve and proceed on his own, but the complaint has not been served. FMCH understands that the US Attorney for Western District of Tennessee is no longer pursuing its investigation of FMCH. The District of Colorado investigation continues.

Beginning October 6, 2015, the United States Attorney for the Eastern District of New York (the “Brooklyn USAO”) and the Office of Inspector General of the United States Department of Health and Human Services (“OIG”) have investigated, through subpoenas issued under the False Claims Act, utilization and invoicing by the Company’s subsidiary Azura Vascular Care for a period beginning after the Company’s acquisition of American Access Care LLC (“AAC”) in October 2011. The Company has cooperated in the government’s inquiry. Allegations against AAC arising in districts in Connecticut, Florida and Rhode Island relating to utilization and invoicing were settled in 2015.

On October 22, 2018, the United States Attorney for the Southern District of New York (the “Manhattan USAO”) announced a False Claims Act settlement for up to $18,400 with Vascular Access Centers LP, a competitor of AAC and Azura. Simultaneously, related documents were unsealed, including the 2012 qui tam (whistleblower) complaint that gave rise to the investigation. Xxxxxx v. Vascular Access Centers, 2012 Civ. 5103 (S.D.N.Y.). That qui tam complaint names as defendants, among others in the dialysis industry, certain affiliates of the Company. At the present time, the Manhattan USAO has not intervened as against non-settling defendants and the relationship, if any, between the Brooklyn USAO investigation of Azura begun in 2015 and the Manhattan USAO’s Xxxxxx settlement is unclear.

On June 30, 2016, FMCH received a subpoena from the United States Attorney for the Northern District of Texas (Dallas) seeking information under the False Claims Act about the use and management of pharmaceuticals including Velphoro® as well as FMCH’s interactions with DaVita. The investigation encompasses DaVita, Amgen, Sanofi, and other pharmaceutical manufacturers and includes inquiries into whether certain compensation transfers between manufacturers and pharmacy vendors constituted unlawful kickbacks. The Company understands that this investigation is substantively independent of the $63,700 settlement by DaVita Rx announced on December 14, 2017 in the matter styled United States ex rel. Gallian v. DaVita Rx, 2016 Civ. 0943 (N.D. Tex.). FMCH is cooperating in the investigation.

On November 18, 2016, FMCH received a subpoena under the False Claims Act from the United States Attorney for the Eastern District of New York (Brooklyn) seeking documents and information relating to the operations of Xxxxx Medical Laboratory, Inc., which FMCH acquired in October 2013. In the course of cooperating in the investigation and preparing to respond to the subpoena, FMCH identified falsifications and misrepresentations in documents submitted by a Shiel salesperson that relate to the integrity of certain invoices submitted by Xxxxx for laboratory testing for patients in long term care facilities. On February 21,

F-4

2017, FMCH terminated the employee and notified the United States Attorney of the termination and its circumstances. The terminated employee’s conduct is expected to result in demands for the Company to refund overpayments and to pay related penalties under applicable laws, but the monetary value of such payment demands cannot yet be reasonably estimated.

On December 12, 2017, the Company sold to Quest Diagnostics certain Xxxxx operations that are the subject of this Brooklyn subpoena, including the misconduct reported to the United States Attorney. Under the sale agreement, the Company retains responsibility for the Brooklyn investigation and its outcome. The Company continues to cooperate in the ongoing investigation.

On December 14, 2016, the Center for Medicare & Medicaid Services (“CMS”), which administers the federal Medicare program, published an Interim Final Rule (“IFR”) titled “Medicare Program; Conditions for Coverage for End-Stage Renal Disease Facilities-Third Party Payment.” The IFR would have amended the Conditions for Coverage for dialysis providers, like FMCH and would have effectively enabled insurers to reject premium payments made by or on behalf of patients who received grants for individual market coverage from the American Kidney Fund (“AKF” or “the Fund”). The IFR could thus have resulted in those patients losing individual insurance market coverage. The loss of coverage for these patients would have had a material and adverse impact on the operating results of FMCH.

On January 25, 2017, a federal district court in Texas responsible for litigation initiated by a patient advocacy group and dialysis providers including FMCH preliminarily enjoined CMS from implementing the IFR. Dialysis Patient Citizens x. Xxxxxxx, 2017 Civ. 0016 (E.D. Texas, Sherman Div.). The preliminary injunction was based on CMS’ failure to follow appropriate notice-and-comment procedures in adopting the IFR. The injunction remains in place and the court retains jurisdiction over the dispute.

On June 22, 2017, CMS requested a stay of proceedings in the litigation pending further rulemaking concerning the IFR. CMS stated, in support of its request, that it expects to publish a Notice of Proposed Rulemaking in the Federal Register and otherwise pursue a notice-and-comment process. Plaintiffs in the litigation, including FMCH, consented to the stay, which was granted by the court on June 27, 2017.

On January 3, 2017, the Company received a subpoena from the United States Attorney for the District of Massachusetts under the False Claims Act inquiring into the Company’s interactions and relationships with the AKF, including the Company’s charitable contributions to the Fund and the Fund’s financial assistance to patients for insurance premiums. FMCH is cooperating in the investigation, which is part of a broader investigation into charitable contributions in the medical industry. The Company believes that the investigation revolves around conduct alleged to be unlawful in United Healthcare v. American Renal Associates, 2018 Civ. 10622 (D. Mass.), but believes that such unlawful conduct was not undertaken by the Company. On July 2, 2018, American Renal Associates announced that it had reached a settlement in principle of the United Healthcare litigation. The Company lacks information necessary to assess how the American Renal Associates settlement may impact the United States Attorney’s investigation.

In early May 2017, the United States Attorney for the Middle District of Tennessee (Nashville) issued identical subpoenas to FMCH and two subsidiaries under the False Claims Act concerning the Company’s retail pharmaceutical business. The investigation is exploring allegations related to improper inducements to dialysis patients to fill oral prescriptions through FMCH’s pharmacy service, improper billing for returned pharmacy products and other allegations similar to those underlying the $63,700 settlement by DaVita Rx in Texas announced on December 14, 2017. United States ex rel. Gallian, 2016 Civ. 0943 (N.D. Tex.). FMCH is cooperating in the investigation.

The Company received a subpoena dated December 11, 2017 from the United States Attorney for the Eastern District of California (Sacramento) requesting information under the False Claims Act concerning Spectra Laboratories, the Company’s affiliate engaged in laboratory testing for dialysis patients. The inquiry related to allegations that certain services or materials provided by Spectra to its outpatient

F-5

dialysis facility customers constitute unlawful kickbacks. The Company cooperated in the investigation. On August 7, 2018, the United States Attorney declined to intervene on a qui tam complaint, which had been filed by an affiliate of industry competitor Ascend Laboratory and caused the investigation to be initiated. On September 4, the competitor/relator dismissed the complaint. Laboratory Research, LLC v. Spectra Laboratories, Inc., 2017 Civ. 1185 (E.D. Cal., June 7, 2017). No settlement discussions occurred and the Company gave no consideration for the dismissal.

From time to time, the Company is a party to or may be threatened with other litigation or arbitration, claims or assessments arising in the ordinary course of its business. Management regularly analyzes current information including, as applicable, the Company’s defenses and insurance coverage and, as necessary, provides accruals for probable liabilities for the eventual disposition of these matters.

The Company, like other healthcare providers, insurance plans and suppliers, conducts its operations under intense government regulation and scrutiny. It must comply with regulations which relate to or govern the safety and efficacy of medical products and supplies, the marketing and distribution of such products, the operation of manufacturing facilities, laboratories, dialysis clinics and other health care facilities, and environmental and occupational health and safety. With respect to its development, manufacture, marketing and distribution of medical products, if such compliance is not maintained, the Company could be subject to significant adverse regulatory actions by the U.S. Food and Drug Administration (“FDA”) and comparable regulatory authorities outside the U.S. These regulatory actions could include warning letters or other enforcement notices from the FDA, and/or comparable foreign regulatory authority which may require the Company to expend significant time and resources in order to implement appropriate corrective actions. If the Company does not address matters raised in warning letters or other enforcement notices to the satisfaction of the FDA and/or comparable regulatory authorities outside the U.S., these regulatory authorities could take additional actions, including product recalls, injunctions against the distribution of products or operation of manufacturing plants, civil penalties, seizures of the Company’s products and/or criminal prosecution. FMCH is currently engaged in remediation efforts with respect to one pending FDA warning letter. The Company must also comply with the laws of the United States, including the federal Anti-Kickback Statute, the federal False Claims Act, the federal Xxxxx Law, the federal Civil Monetary Penalties Law and the federal Foreign Corrupt Practices Act as well as other federal and state fraud and abuse laws. Applicable laws or regulations may be amended, or enforcement agencies or courts may make interpretations that differ from the Company’s interpretations or the manner in which it conducts its business. Enforcement has become a high priority for the federal government and some states. In addition, the provisions of the False Claims Act authorizing payment of a portion of any recovery to the party bringing the suit encourage private plaintiffs to commence whistleblower actions. By virtue of this regulatory environment, the Company’s business activities and practices are subject to extensive review by regulatory authorities and private parties, and continuing audits, subpoenas, other inquiries, claims and litigation relating to the Company’s compliance with applicable laws and regulations. The Company may not always be aware that an inquiry or action has begun, particularly in the case of whistleblower actions, which are initially filed under court seal.

The Company operates many facilities and handles the personal data (“PD”) of its patients and beneficiaries throughout the United States and other parts of the world, and engages with other business associates to help it carry out its health care activities. In such a decentralized system, it is often difficult to maintain the desired level of oversight and control over the thousands of individuals employed by many affiliated companies and its business associates. On occasion, the Company or its business associates may experience a breach under the Health Insurance Portability and Accountability Act Privacy Rule and Security Rules, the EU’s General Data Protection Regulation and or other similar laws (“Data Protection Laws”) when there has been impermissible use, access, or disclosure of unsecured PD or when the Company or its business associates neglect to implement the required administrative,

F-6

technical and physical safeguards of its electronic systems and devices, or a data breach that results in impermissible use, access or disclosure of personal identifying information of its employees, patients and beneficiaries. On those occasions, the Company must comply with applicable breach notification requirements.

The Company relies upon its management structure, regulatory and legal resources, and the effective operation of its compliance program to direct, manage and monitor the activities of its employees. On occasion, the Company may identify instances where employees or other agents deliberately, recklessly or inadvertently contravene the Company’s policies or violate applicable law. The actions of such persons may subject the Company and its subsidiaries to liability under the Anti-Kickback Statute, the Xxxxx Law, the False Claims Act, Data Protection Laws, the Health Information Technology for Economic and Clinical Health Act and the Foreign Corrupt Practices Act, among other laws and comparable state laws or laws of other countries.

Physicians, hospitals and other participants in the healthcare industry are also subject to a large number of lawsuits alleging professional negligence, malpractice, product liability, worker’s compensation or related claims, many of which involve large claims and significant defense costs. The Company has been and is currently subject to these suits due to the nature of its business and expects that those types of lawsuits may continue. Although the Company maintains insurance at a level which it believes to be prudent, it cannot assure that the coverage limits will be adequate or that insurance will cover all asserted claims. A successful claim against the Company or any of its subsidiaries in excess of insurance coverage could have a material adverse effect upon it and the results of its operations. Any claims, regardless of their merit or eventual outcome, could have a material adverse effect on the Company’s reputation and business.

The Company has also had claims asserted against it and has had lawsuits filed against it relating to alleged patent infringements or businesses that it has acquired or divested. These claims and suits relate both to operation of the businesses and to the acquisition and divestiture transactions. The Company has, when appropriate, asserted its own claims, and claims for indemnification. A successful claim against the Company or any of its subsidiaries could have a material adverse effect upon its business, financial condition, and the results of its operations. Any claims, regardless of their merit or eventual outcome, could have a material adverse effect on the Company’s reputation and business.

In Germany, the tax audits for the years 2006 through 2009 have been substantially completed. The German tax authorities have indicated a re-qualification of dividends received in connection with intercompany mandatorily redeemable preferred shares into fully taxable interest payments for these and subsequent years until 2013 and the disallowance of certain other tax deductions. The Company has defended its position and will avail itself of appropriate remedies. An adverse determination with respect to fully taxable interest payments related to intercompany mandatorily redeemable preferred shares and the disallowance of certain other tax deductions could have a material adverse effect on the Company’s financial condition and results of operations.

The Company is also subject to ongoing and future tax audits in the U.S., Germany and other jurisdictions in the ordinary course of business. Tax authorities routinely pursue adjustments to the Company’s tax returns and disallowances of claimed tax deductions. When appropriate, the Company defends these adjustments and disallowances and asserts its own claims. A successful tax related claim against the Company or any of its subsidiaries could have a material adverse effect upon its business, financial condition and results of operations. Any claims, regardless of their merit or eventual outcome, could have a material adverse effect on the Company’s reputation and business.

Other than those individual contingent liabilities mentioned above, the current estimated amount of the Company’s other known individual contingent liabilities is immaterial.

F-7

Exhibit 2

to Amendment

EXHIBIT G

SECOND AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT

LOCATION OF RECORDS

[attached]

EXHIBIT G

SECOND AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT

LOCATION OF RECORDS

Number

TAA Name

TAX ID

TAA

Ed to FIDB

Billing Group Name1

Xxxx0

XX0

Xxx0

Apheresis Care Group, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Alabama, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of California, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Delaware, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Dover, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Florida, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Georgia, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Illinois, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Indiana, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Kansas, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Kentucky, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Louisiana, LLC

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Maine, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Manchester, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Maryland, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Massachusetts, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Michigan, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Minnesota, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Mississippi, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Missouri, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of New Hampshire, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of New Jersey, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Xxx-Xxxxxxx Xxxxxxxxxxxx xx Xxx Xxxxxx, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of North Carolina, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Ohio, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Oklahoma, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Pennsylvania, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Xxx-Xxxxxxx Xxxxxxxxxxxx xx Xxxxx Xxxxxxxx, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Tennessee, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Texas, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of the District of Columbia, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Virginia, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Xxx-Xxxxxxx Xxxxxxxxxxxx xx Xxxx Xxxxxxxx, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Wisconsin, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Wyoming, LLC

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Dialysis America Georgia, LLC

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Dialysis Centers of America - Illinois, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Dialysis Management Corporation

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Dialysis Services of Atlanta, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Dialysis Services of Cincinnati, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Everest Healthcare Rhode Island, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Four State Regional Dialysis Center, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Fresenius Medical Care Dialysis Services - Oregon, LLC

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

Fresenius Medical Care Dialysis Services Colorado LLC

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

101

Fresenius Medical Care of Montana, LLC

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

108

Gulf Region Mobile Dialysis, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

109

Haemo-Stat, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

115

Inland Northwest Renal Care Group, LLC

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

125

National Nephrology Associates of Texas, L.P.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

126

New York Dialysis Services, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

127

NNA of Alabama, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

129

NNA of Georgia, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

134

NNA of Rhode Island, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

135

NNA of Toledo, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

148

NRA-lnpatient Dialysis, LLC

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

166

Physicians Dialysis Company, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

184

RAI Care Centers of Nebraska II, LLC

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

195

RCG Indiana, L.L.C.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

204

Renal Care Group East, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

206

Renal Care Group Northwest, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

207

Renal Care Group of the Midwest, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

210

Renal Care Group of the South, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

211

Renal Care Group of the Southeast, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

000

Xxxxx Xxxx Xxxxx Xxxxx Xxx Xxxxxx, LLC

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

214

Renal Care Group Southwest, L.P.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

216

Renal Care Group Texas, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

229

Renex Dialysis Clinic of Woodbury, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

231

Saint Louis Renal Care, LLC

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

232

San Diego Dialysis Services, Inc.

00-0000000

Yes

00-0000000

ATLANTAACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

000

Xxxx Xxx Dialysis Center, Inc.

00-0000000

Yes

00-0000000

ATLANTA ACUTE BILLING GROUP

0000 XXXXX XX XX

XXXXXXXX

00000

110

Hauppauge Dialysis Center, LLC

00-0000000

Yes

00-0000000

CLEVELAND BILLING GROUP

00000 XXXXXXX XXXX XXXX

XXXXX XXXXXXX

00000

120

Liverpool LD, LLC

00-0000000

Yes

00-0000000

CLEVELAND BILLING GROUP

00000 XXXXXXX XXXX XXXX

XXXXX XXXXXXX

00000

128

NNA of East Orange, L.L.C.

00-0000000

Yes

00-0000000

CLEVELAND BILLING GROUP

00000 XXXXXXX XXXX XXXX

XXXXX XXXXXXX

00000

130

NNA of Xxxxxxxx, L.L.C.

00-0000000

Yes

00-0000000

CLEVELAND BILLING GROUP

00000 XXXXXXX XXX X XXXX

XXXXX XXXXXXX

00000

205

Renal Care Group Maplewood, LLC

00-0000000

Yes

00-0000000

CLEVELAND BILLING GROUP

00000 XXXXXXX XXXX XXXX

XXXXX XXXXXXX

00000

219

Renex Dialysis Clinic of Bloomfield, Inc.

00-0000000

Yes

00-0000000

CLEVELAND BILLING GROUP

00000 XXXXXXX XXXX XXXX

XXXXX XXXXXXX

00000

223

Renex Dialysis Clinic of Orange, Inc.

00-0000000

Yes

00-0000000

CLEVELAND BILLING GROUP

00000 XXXXXXX XXXX XXXX

XXXXX XXXXXXX

00000

Bio-Medical Applications Management Company, Inc.

00-0000000

Yes

#N/A

Fresenius Medical Care

000 Xxxxxx Xx

Xxxxxxx

00000

Bio-Medical Applications of Fayetteville, Inc.

00-0000000

Yes

00-0000000

Fresenius Medical Care

000 Xxxxxx Xx

Xxxxxxx

00000

Bio-Medical Applications of Rhode Island, Inc.

00-0000000

Yes

00-0000000

Fresenius Medical Care

000 Xxxxxx Xx

Xxxxxxx

00000

Everest Healthcare Holdings, Inc.

00-0000000

Yes

#N/A

Fresenius Medical Care

000 Xxxxxx Xx

Xxxxxxx

00000

G-1

Fresenius Management Services, Inc.

00-0000000

Yes

00-0000000

Fresenius Medical Care

000 Xxxxxx Xx

Xxxxxxx

00000

Fresenius Medical Care Holdings, Inc.

00-0000000

Yes

#N/A

Fresenius Medical Care

000 Xxxxxx Xx

Xxxxxxx

00000

102

Fresenius Medical Care Ventures, LLC

00-0000000

Yes

00-0000000

Fresenius Medical Care

000 Xxxxxx Xx

Xxxxxxx

00000

103

Fresenius Medical Care West Bexar, LLC

00-0000000

Yes

00-0000000

Fresenius Medical Care

000 Xxxxxx Xx

Xxxxxxx

00000

105

Fresenius USA Manufacturing, Inc.

00-0000000

Yes

#N/A

Fresenius Medical Care

000 Xxxxxx Xx

Xxxxxxx

00000

106

Fresenius USA Marketing, Inc.

00-0000000

Yes

#N/A

Fresenius Medical Care

000 Xxxxxx Xx

Xxxxxxx

00000

107

Fresenius USA, Inc.

00-0000000

Yes

#N/A

Fresenius Medical Care

000 Xxxxxx Xx

Xxxxxxx

00000

124

National Medical Care, Inc.

00-0000000

Yes

00-0000000

Fresenius Medical Care

000 Xxxxxx Xx

Xxxxxxx

00000

121

Maumee Dialysis Services, LLC

00-0000000

Yes

00-0000000

INDIANAPOLIS BILLING GROUP

0000 XXXX XXXXXX XX

XXXXXX

00000

193

RCG Bloomington, LLC

00-0000000

Yes

00-0000000

INDIANAPOLIS BILLING GROUP

0000 XXXX XXXXXX XX

XXXXXX

00000

213

Renal Care Group Southwest Michigan, LLC

00-0000000

Yes

00-0000000

INDIANAPOLIS BILLING GROUP

0000 XXXX XXXXXX XX

XXXXXX

00000

215

Renal Care Group Terre Haute, LLC

00-0000000

Yes

00-0000000

INDIANAPOLIS BILLING GROUP

0000 XXXX XXXXXX XX

XXXXXX

00000

224

Renex Dialysis Clinic of Pittsburgh, Inc.

00-0000000

Yes

00-0000000

INDIANAPOLIS BILLING GROUP

0000 XXXX XXXXXX XX

XXXXXX

00000

Bio-Medical Applications of Aguadilla, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

Bio-Medical Applications of Arecibo, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

Bio-Medical Applications of Arkansas, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

Bio-Medical Applications of Bayamon, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

Bio-Medical Applications of Caguas, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

Bio-Medical Applications of Carolina, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

Bio-Medical Applications of Guayama, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

Bio-Medical Applications of Humacao, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

Bio-Medical Applications of Mayaguez, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

Bio-Medical Applications of Xxxxx, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

Bio-Medical Applications of Puerto Rico, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

Bio-Medical Applications of Rio Piedras, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

Bio-Medical Applications of San German, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

Bio-Medical Applications of San Xxxx, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

Brevard County Dialysis, LLC

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

Clermont Dialysis Center, LLC

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

Xxxxxxx Dialysis Clinic, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

Fresenius Medical Care Capital City, LLC

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

114

Homestead Artificial Kidney Center, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

116

Jefferson County Dialysis, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

117

KDCO, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

119

Little Rock Dialysis, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

122

Metro Dialysis Center - Normandy, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

123

Metro Dialysis Center - North, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

131

NNA of Louisiana, LLC

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

157

NRA-Roanoke, Alabama, LLC

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

161

NRA-Talladega, Alabama, LLC

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

000

XXX Xxxx Xxxxxxx xx Xxxxxxx, LLC

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

176

RAI Care Centers of Florida I, LLC

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

177

RAI Care Centers of Florida II, LLC

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

000

XXX Xxxx Xxxxx, LLP

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

197

RCG Xxxxxx, LLC

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

198

RCG Memphis East, LLC

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

199

RCG Mississippi, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

200

RCG Pensacola, LLC

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

208

Renal Care Group of the Ozarks, LLC

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

220

Renex Dialysis Clinic of Bridgeton, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

221

Renex Dialysis Clinic of Creve Coeur, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

222

Renex Dialysis Clinic of Maplewood, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

226

Renex Dialysis Clinic of St. Louis, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

227

Renex Dialysis Clinic of Tampa, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

228

Renex Dialysis Clinic of University City, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

230

Renex Dialysis Facilities, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

236

St. Louis Regional Dialysis Center, Inc.

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

239

Stuttgart Dialysis, LLC

00-0000000

Yes

00-0000000

LAKESIDE BILLING GROUP

0000 X XXXXXXXX XXXX

XXXXXXXX

00000

Bio-Medical Applications of Camarillo, Inc.

00-0000000

Yes

00-0000000

MESA BILLING GROUP

0000 X XXXX XX

XXXX

00000

Bio-Medical Applications of Eureka, Inc.

00-0000000

Yes

00-0000000

MESA BILLING GROUP

0000 X XXXX XX

XXXX

00000

Bio-Medical Applications of Fremont, Inc.

00-0000000

Yes

00-0000000

MESA BILLING GROUP

0000 X XXXX XX

XXXX

00000

Bio-Medical Applications of Fresno, Inc.

00-0000000

Yes

00-0000000

MESA BILLING GROUP

0000 X XXXX XX

XXXX

00000

Bio-Medical Applications of Los Gatos, Inc.

00-0000000

Yes

00-0000000

MESA BILLING GROUP

0000 X XXXX XX

XXXX

00000

Conejo Valley Dialysis, Inc.

00-0000000

Yes

00-0000000

MESA BILLING GROUP

0000 X XXXX XX

XXXX

00000

167

QualiCenters Albany, Ltd.

00-0000000

Yes

00-0000000

MESA BILLING GROUP

0000 X XXXX XX

XXXX

00000

169

QualiCenters Coos Bay, Ltd.

00-0000000

Yes

00-0000000

MESA BILLING GROUP

0000 X XXXX XX

XXXX

00000

000

XXX Xxxx Xxxxxxx xx Xxxxxxxx Xxxxxxxxxx I, LLC

00-0000000

Yes

00-0000000

MESA BILLING GROUP

0000 X XXXX XX

XXXX

00000

000

XXX Xxxx Xxxxxxx xx Xxxxxxxx Xxxxxxxxxx II, LLC

00-0000000

Yes

00-0000000

MESA BILLING GROUP

0000 X XXXX XX

XXXX

00000

188

RAI Care Centers of Oakland II, LLC

00-0000000

Yes

00-0000000

MESA BILLING GROUP

0000 X XXXX XX

XXXX

00000

000

XXX Xxxx Xxxxxxx xx Xxxxxxxx Xxxxxxxxxx I, LLC

00-0000000

Yes

00-0000000

MESA BILLING GROUP

0000 X XXXX XX

XXXX

00000

000

XXX Xxxx Xxxxxxx xx Xxxxxxxx Xxxxxxxxxx II, LLC

00-0000000

Yes

00-0000000

MESA BILLING GROUP

0000 X XXXX XX

XXXX

00000

203

Renal Care Group Alaska, Inc.

00-0000000

Yes

00-0000000

MESA BILLING GROUP

0000 X XXXX XX

XXXX

00000

233

Santa Xxxxxxx Community Dialysis Center, Inc.

00-0000000

Yes

00-0000000

MESA BILLING GROUP

0000 X XXXX XX

XXXX

00000

Bio-Medical Applications of Clinton, Inc.

00-0000000

Yes

00-0000000

NASHVILLE BILLING GROUP

0000 X XXXXXX XX

XXXXXXXX

00000

Everest Healthcare Indiana, Inc.

00-0000000

Yes

00-0000000

NASHVILLE BILLING GROUP

0000 X XXXXXX XX

XXXXXXXX

00000

113

Home Dialysis of Muhlenberg County, Inc.

00-0000000

Yes

00-0000000

NASHVILLE BILLING GROUP

0000 X XXXXXX XX

XXXXXXXX

00000

118

Kentucky Renal Care Group, LLC

00-0000000

Yes

00-0000000

NASHVILLE BILLING GROUP

0000 X XXXXXX XX

XXXXXXXX

00000

000

XXX-Xxxxxxxxxx, Xxxxxxxxx, LLC

00-0000000

Yes

00-0000000

NASHVILLE BILLING GROUP

0000 X XXXXXX XX

XXXXXXXX

00000

000

XXX-Xxxxxxxxxx, Xxxxxxxx, LLC

00-0000000

Yes

00-0000000

NASHVILLE BILLING GROUP

1500 X XXXXXX XX

XXXXXXXX

00000

140

XXX-Xxxxxxxxxx, Xxxxxxxx, LLC

00-0000000

Yes

00-0000000

NASHVILLE BILLING GROUP

1500 X XXXXXX XX

XXXXXXXX

00000

150

XXX-Xxx Xxxxxx, Xxxxxxx, LLC

00-0000000

Yes

00-0000000

NASHVILLE BILLING GROUP

1500 X XXXXXX XX

XXXXXXXX

00000

150

XXX-Xxxxxxxxx, Xxxxxxxx, LLC

00-0000000

Yes

00-0000000

NASHVILLE BILLING GROUP

1500 X XXXXXX XX

XXXXXXXX

00000

150

XXX-Xxxxx Xxxx, Xxxxxxxx, LLC

00-0000000

Yes

00-0000000

NASHVILLE BILLING GROUP

1500 X XXXXXX XX

XXXXXXXX

00000

150

XXX-Xx. Xxxxx (Xxxx Xxxxxxx Xxxxxx), Xxxxxxxx, LLC

00-0000000

Yes

00-0000000

NASHVILLE BILLING GROUP

1500 X XXXXXX XX

XXXXXXXX

00000

160

XXX-Xx. Xxxxx, Xxxxxxxx, LLC

00-0000000

Yes

00-0000000

NASHVILLE BILLING GROUP

1500 X XXXXXX XX

XXXXXXXX

00000

164

NRA-Washington County, Missouri, LLC

00-0000000

Yes

00-0000000

NASHVILLE BILLING GROUP

1500 X XXXXXX XX

XXXXXXXX

00000

160

XXX-Xxxxxxxxxx, Xxxxxxx, LLC

00-0000000

Yes

00-0000000

NASHVILLE BILLING GROUP

1500 X XXXXXX XX

XXXXXXXX

00000

182

RAI Care Centers of Michigan I, LLC

00-0000000

Yes

00-0000000

NASHVILLE BILLING GROUP

1500 X XXXXXX XX

XXXXXXXX

00000

183

RAI Care Centers of Michigan II, LLC

00-0000000

Yes

00-0000000

NASHVILLE BILLING GROUP

1500 X XXXXXX XX

XXXXXXXX

00000

185

RAI Care Centers of North Carolina II, LLC

00-0000000

Yes

00-0000000

NASHVILLE BILLING GROUP

1500 X XXXXXX XX

XXXXXXXX

00000

G-2

202

RCG University Division, Inc.

00-0000000

Yes

00-0000000

NASHVILLE BILLING GROUP

1500 X XXXXXX XX

XXXXXXXX

00000

Bio-Medical Applications of Connecticut, Inc.

00-0000000

Yes

00-0000000

NEW BEDFORD BILLING GROUP

700 PLEASANT ST

NEW BEDFORD

2740

Bio-Medical Applications of Anacostia, Inc.

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Columbia Heights, Inc.

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Northeast D.C., Inc.

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Southeast Washington, Inc.

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

Xxxxxxx County Dialysis, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

College Park Dialysis, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

Columbus Area Renal Alliance, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

Dialysis Specialists of Marietta, Ltd.

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

Xxxxxxx County Dialysis, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

Everest Healthcare Ohio, Inc.

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

FMS Delaware Dialysis, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

FMS Philadelphia Dialysis, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

Fresenius Medical Care Xxxxxxx Hall, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

104

Fresenius Medical Care-OSUIM Kidney Centers, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

111

Xxxxx Dialysis Center, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

112

Xxxxxx Dialysis Clinic, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

140

XXX-Xxxxxxx, Xxxxxxx, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

140

XXX-Xxxxxxx, Xxxxx Xxxxxxxx, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

145

NRA-Hogansville, Georgia, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

140

XXX-Xxxxx Xxxx, Xxxxx Xxxxxxxx, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

140

XXX-Xxxxxxxxx, Xxxxx Xxxxxxxx, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

149

NRA-LaGrange, Georgia, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

150

XXX-Xx. Xxxxxxxx, Xxxxx Xxxxxxxx, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

152

NRA-Newnan Acquisition, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

150

XXX-Xxxxx Xxxxxxx, Xxxxx Xxxxxxxx, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

150

XXX-Xxxxxxxxxx, Xxxxx Xxxxxxxx, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

150

XXX-Xxxxxxxx, Xxxxxxx, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

160

XXX-Xxxxxxxx (Xxxxx), Xxxxxxx, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

163

NRA-Valdosta, Georgia, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

178

RAI Care Centers of Georgia I, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

181

RAI Care Centers of Maryland I, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

180

XXX Xxxx Xxxxxxx xx Xxxxx Xxxxxxxx X, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

192

RAI Care Centers of Virginia I, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

217

Renal Care Group Toledo, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

225

Renex Dialysis Clinic of South Georgia, Inc.

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

234

Smyrna Dialysis Center, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

238

Stone Mountain Dialysis Center, LLC

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

240

Tappahannock Dialysis Center, Inc.

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

242

Warrenton Dialysis Facility, Inc.

00-0000000

Yes

00-0000000

PEACHTREE BILLING GROUP

1900 XXXXX XX XX

XXXXXXXX

00000

Bio-Medical Applications of Amarillo, Inc.

00-0000000

Yes

00-0000000

TYLER BILLING GROUP

1100 X. XX XXXX 000

XXXXX

00000

Bio-Medical Applications of Blue Springs, Inc.

00-0000000

Yes

00-0000000

TYLER BILLING GROUP

1100 X. XX XXXX 000

XXXXX

00000

Dialysis Specialists of Topeka, Inc.

00-0000000

Yes

00-0000000

TYLER BILLING GROUP

1100 X. XX XXXX 000

XXXXX

00000

Du Page Dialysis, Ltd.

00-0000000

Yes

00-0000000

TYLER BILLING GROUP

1100 X. XX XXXX 000

XXXXX

00000

Everest Healthcare Texas, L.P.

00-0000000

Yes

00-0000000

TYLER BILLING GROUP

1100 X. XX XXXX 000

XXXXX

00000

Fort Xxxxx Regional Dialysis Center, Inc.

00-0000000

Yes

00-0000000

TYLER BILLING GROUP

1100 X. XX XXXX 000

XXXXX

00000

Xxxxxxxxx Xxxxxxx Xxxx - Xxxxx Xxxxx Xidney, LLC

00-0000000

Yes

00-0000000

TYLER BILLING GROUP

1100 X. XX XXXX 000

XXXXX

00000

100

Xxxxxxxxx Xxxxxxx Xxxx xx Xxxxxxxx, LLC

00-0000000

Yes

00-0000000

TYLER BILLING GROUP

1100 X. XX XXXX 000

XXXXX

00000

132

NNA of Oklahoma, Inc.

00-0000000

Yes

#N/A

TYLER BILLING GROUP

1100 X. XX XXXX 000

XXXXX

00000

133

NNA of Oklahoma, L.L.C.

00-0000000

Yes

00-0000000

TYLER BILLING GROUP

1100 X. XX XXXX 000

XXXXX

00000

139

NRA-Ada, Oklahoma, LLC

00-0000000

Yes

00-0000000

TYLER BILLING GROUP

1100 X. XX XXXX 000

XXXXX

00000

179

RAI Care Centers of Illinois I, LLC

00-0000000

Yes

00-0000000

TYLER BILLING GROUP

1100 X. XX XXXX 000

XXXXX

00000

180

RAI Care Centers of Illinois II, LLC

00-0000000

Yes

00-0000000

TYLER BILLING GROUP

1100 X. XX XXXX 000

XXXXX

00000

196

RCG Irving, LLP

00-0000000

Yes

00-0000000

TYLER BILLING GROUP

1100 X. XX XXXX 000

XXXXX

00000

201

RCG Robstown, LLP

00-0000000

Yes

00-0000000

TYLER BILLING GROUP

1100 X. XX XXXX 000

XXXXX

00000

209

Renal Care Group of the Rockies, LLC

00-0000000

Yes

00-0000000

TYLER BILLING GROUP

1100 X. XX XXXX 000

XXXXX

00000

218

Renal Care Group-Harlingen, L.P.

00-0000000

Yes

00-0000000

TYLER BILLING GROUP

1100 X. XX XXXX 000

XXXXX

00000

235

SSKG, Inc.

00-0000000

Yes

00-0000000

TYLER BILLING GROUP

1100 X. XX XXXX 000

XXXXX

00000

237

STAT Dialysis Corporation

00-0000000

Yes

00-0000000

TYLER BILLING GROUP

1100 X. XX XXXX 000

XXXXX

00000

241

Xxxxxxx Dialysis Center, L.L.C.

00-0000000

Yes

00-0000000

TYLER BILLING GROUP

1100 X. XX XXXX 000

XXXXX

00000

244

WSKC Dialysis Services, Inc.

00-0000000

Yes

00-0000000

TYLER BILLING GROUP

1100 X. XX XXXX 000

XXXXX

00000

Dialysis Associates of Northern New Jersey, L.L.C.

00-0000000

Use

00-0000000

CLEVELAND

25000 XXXXXXX XXXX XXXX

XXXXX XXXXXXX

00000

Fresenius Kidney Care Pittsburgh, LLC

00-0000000

Use

00-0000000

PEACHTREE

1900 XXXXX XX XX

XXXXXXXX

00000

136

NNA-Saint Barnabas, L.L.C.

00-0000000

Use

00-0000000

CLEVELAND

25000 XXXXXXX XXXX XXXX

XXXXX XXXXXXX

00000

130

XXX-Xxxxx Xxxxxxxx-Xxxxxxxxxx, L.L.C.

00-0000000

Use

00-0000000

CLEVELAND

25000 XXXXXXX XXXX XXXX

XXXXX XXXXXXX

00000

138

Northern New Jersey Dialysis, L.L.C.

00-0000000

Use

00-0000000

CLEVELAND

25000 XXXXXXX XXXX XXXX

XXXXX XXXXXXX

00000

168

QualiCenters Bend, LLC

00-0000000

Use

00-0000000

MESA

1700 X XXXX XX

XXXX

00000

170

QualiCenters Eugene-Springfield Ltd.

00-0000000

Use

00-0000000

MESA

1700 X XXXX XX

XXXX

00000

171

QualiCenters Inland Northwest LLC

00-0000000

Use

00-0000000

MESA

1700 X XXXX XX

XXXX

00000

172

QualiCenters Pueblo LLC

00-0000000

Use

00-0000000

TYLER

1700 X XXXX XX

XXXX

00000

173

QualiCenters Salem, LLC

00-0000000

Use

00-0000000

MESA

1700 X XXXX XX

XXXX

00000

174

QualiCenters Sioux City LLC

00-0000000

Use

00-0000000

TYLER

1100 X. XX XXXX 000

XXXXX

00000

G-3

Exhibit 3

to Amendment

EXHIBIT H

SECOND AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT

LIST OF SELLER’S SUBSIDIARIES, DIVISIONS AND TRADENAMES

Wholly owned:

Bio-Medical Applications Management Company, Inc.

Bio-Medical Applications of Illinois, Inc.

Dialysis America Alabama, LLC

Fresenius Medical Care Dialysis Services - Oregon, LLC

Fresenius Medical Care Insurance Group, LLC

Fresenius Medical Care of Illinois, LLC

Fresenius Medical Seamless Care, LLC

Fresenius Medical Care Ventures Holding Company, Inc.

Haemo-Stat, Inc.

Home Intensive Care, Inc.

Lallendorf Road Realty, LLC

NMC A, LLC

NMC Funding Corporation

NMC Services, Inc.

QCI Holdings, Inc.

Quality Care Dialysis Center of Xxxx Baja, Inc.

Renal Research Institute, LLC

Spectra Renal Research, LLC

U.S. Vascular Access Holdings, LLC

Elevate365, LLC

New Highway Realty, LLC

Netherland Realty, LLC

Muskegon New Realty, LLC

Houston Coffee Real Estate, LLC

Partially owned (other member is another wholly owned entity):

QualiCenters Eugene-Springfield, Ltd. (49%)

QualiCenters Inland Northwest L.L.C. (30%)

QualiCenters Louisville LLC (20%)

QualiCenters Salem LLC (40%)

QualiCenters Sioux City, LLC (49%)

Fresenius Medical Care Lake County, LLC (25.38%)

Tradenames:

Seller: Fresenius Medical Care North America

H-1

Subsidiaries: Fresenius Vascular Care

Azura Vascular Care

Elevate365

H-2

Exhibit 4

to Amendment

FORM OF AMENDMENT NO. 7

TO TRANSFERRING AFFILIATE LETTER

[attached]

EXECUTION VERSION

AMENDMENT NO. 7

Dated as of December 20, 2018

AMENDED AND RESTATED TRANSFERRING AFFILIATE LETTER

Dated as of October 16, 2008

THIS AMENDMENT NO. 7 (this “Amendment”) dated as of December 20, 2018 is entered into by and among (i) NATIONAL MEDICAL CARE, INC., a Delaware corporation (the “Seller”), (ii) the entities listed on the signature pages hereof under the heading “New Transferring Affiliates” (together, the “New Transferring Affiliates”) and (iii) the other entities listed on the signature pages hereof under the heading “Existing Transferring Affiliates” (collectively, the “Existing Transferring Affiliates” and, together with the New Transferring Affiliates, the “Transferring Affiliates”).

PRELIMINARY STATEMENT

A. The Seller and the Existing Transferring Affiliates are parties to that certain Amended and Restated Transferring Affiliate Letter dated as of October 16, 2008 (as amended or otherwise modified prior to the date hereof, the “Transferring Affiliate Letter”). Capitalized terms used herein and not otherwise defined shall have the meanings ascribed to them in the Transferring Affiliate Letter or in the “Agreement” referred to therein.

B. The parties hereto desire to add the New Transferring Affiliates and remove certain Existing Transferring Affiliate as Transferring Affiliates under the Transferring Affiliate Letter and to amend the Transferring Affiliate Letter on the terms and conditions hereinafter set forth.

SECTION 1. Amendments.

Subject to the satisfaction of the conditions precedent set forth in Section 2 below, the Transferring Affiliate Letter is hereby amended as follows:

1.1 New Transferring Affiliates. Each of the following entities listed below is a New Transferring Affiliate and is hereby added as a “Transferring Affiliate” under the Transferring Affiliate Letter:

New Transferring Affiliates

Fresenius Kidney Care Pittsburgh, LLC

College Park Dialysis, LLC

Fresenius Medical Care Capital City, LLC

From and after the effective date of this Amendment, each New Transferring Affiliate shall have all of the rights and obligations of a Transferring Affiliate under the Transferring Affiliate Letter. Accordingly, on the effective date of this Amendment, each New Transferring Affiliate shall sell to the Seller, and the Seller shall forthwith purchase from such New Transferring Affiliate, all of the Receivables with respect to the New Transferring Affiliate and all Related Security with respect thereto. All Receivables with respect to such New Transferring Affiliate arising after the effective date of this Amendment and all Related Security with respect thereto shall be sold to the Seller pursuant to the terms of the Transferring Affiliate Letter in the same manner as if such New Transferring Affiliate had been an original party thereto.

1.2 Terminated Transferring Affiliates. Each of the Existing Transferring Affiliates listed below (each, a “Terminated Transferring Affiliate”) is hereby terminated as a “Transferring Affiliate” under the Transferring Affiliate Letter from and after the effective date of this Amendment:

Terminated Transferring Affiliates

Fresenius Medical Care Ventures Holding Company, Inc.

Bio-Medical Applications of Capitol Hill, Inc.

Bio-Medical Applications of Oakland, Inc.

Bio-Medical Applications of Ukiah, Inc.

Bio-Medical Applications of Woonsocket, Inc.

Everest Healthcare Texas Holding Corp.

Fresenius Medical Care Apheresis Services, LLC

Fresenius Medical Care Healthcare Recruitment, LLC

Fresenius Medical Care of Nebraska, LLC

Fresenius Medical Care PSO, LLC

Home Dialysis of America, Inc.

National Nephrology Associates Management Company of Texas, Inc.

NMC Services, Inc.

NNA of Nevada, Inc.

NNA Management Company of Kentucky, Inc.

NNA Management Company of Louisiana, Inc.

North Xxxxxxx Dialysis Center, Inc.

NRA-Bay City, Texas, LLC

QualiCenters, Inc.

RAI Care Centers of Tennessee, LLC

RCG Memphis, LLC

Renal Care Group Michigan, Inc.

Renal Care Group Ohio, Inc.

Renal Care Group Southwest Holdings, Inc.

Renex Corp.

Renex Dialysis Clinic of Philadelphia, Inc.

Xxxxxxx Dialysis, Inc.

From and after the effective date of this Amendment, each of the parties hereto agrees that each Terminated Transferring Affiliate shall have no further rights or obligations to transfer any of its Receivables hereunder and shall cease to be a “Transferring Affiliate” hereunder.

SECTION 2. Conditions Precedent. This Amendment shall become effective and be deemed effective as of the date hereof upon (i) the receipt by the Seller of counterparts of this Amendment duly executed by the Seller and the Transferring Affiliates and (ii) the effectiveness of Amendment No. 2, dated as of the date hereof (the “TAA Amendment”), to the Seventh Amended and Restated Transfer and Administration Agreement.

SECTION 3. Covenants, Representations and Warranties of the Transferring Affiliates.

3.1 Upon the effectiveness of this Amendment, each New Transferring Affiliate (i) represents and warrants that (A) it is, directly or indirectly, a wholly-owned subsidiary of FMCH, (B) it is primarily engaged in the same business as is conducted on the date hereof by the Originating Entities and (C) each statement set forth in Section 6 of the Transferring Affiliate Letter is true and correct in respect of such New Transferring Affiliate, and (ii) hereby makes the Perfection Representations and all covenants as a Transferring Affiliate in the Transferring Affiliate Letter (as amended hereby).

3.2 Upon the effectiveness of this Amendment, each Existing Transferring Affiliate hereby reaffirms all covenants, representations and warranties made by it in the Transferring Affiliate Letter (as amended hereby) and agrees that all such covenants, representations and warranties shall be deemed to have been remade as of the effective date of this Amendment.

3.3 Each Transferring Affiliate hereby represents and warrants that this Amendment constitutes the legal, valid and binding obligation of such party, enforceable against it in accordance with terms hereof.

3.4 Notwithstanding the termination of a Terminated Transferring Affiliate as a Transferring Affiliate under the Transferring Affiliate Letter, after the termination of such Terminated Transferring Affiliate on the date hereof, with respect to any covenant or undertaking required to be performed by the Seller under the Agreement which relates to any Collections, accounts or the assets or properties of such Terminated Transferring Affiliate, the Terminated Transferring Affiliate agrees to take all action, or if applicable to omit to take any action, the taking (or omission to take) of which enables the Seller to comply fully and on a timely basis with the terms and conditions of such covenant or undertaking.

3.5 Upon the effectiveness of this Amendment, the Seller hereby represents, warrants and affirms that, excluding the Terminated Transferring Affiliates, the list of entities on

the signature pages hereof under the headings “New Transferring Affiliates” and “Existing Transferring Affiliates” is, together, a complete and accurate list of all of the Transferring Affiliates that are a party to the Transferring Affiliate Letter.

SECTION 4. Reference to and Effect on the Transferring Affiliate Letter.

4.1 Upon the effectiveness of this Amendment, each reference in the Transferring Affiliate Letter to “Transferring Affiliate Letter,” “hereunder,” “hereof,” “herein,” “hereby” or words of like import shall mean and be a reference to the Transferring Affiliate Letter as amended hereby, and each reference to the Transferring Affiliate Letter in any other document, instrument and agreement executed and/or delivered in connection with the Transferring Affiliate Letter shall mean and be a reference to the Transferring Affiliate Letter as amended hereby.

4.2 Except as specifically amended hereby, the Transferring Affiliate Letter and all other documents, instruments and agreements executed and/or delivered in connection therewith shall remain in full force and effect and are hereby ratified and confirmed.

4.3 The execution, delivery and effectiveness of this Amendment shall not operate as a waiver of any right, power or remedy of the Seller or any of its assignees under the Transferring Affiliate Letter or any other document, instrument, or agreement executed in connection therewith, nor constitute a waiver of any provision contained therein.

SECTION 5. Governing Law. THIS AMENDMENT SHALL BE GOVERNED AND CONSTRUED IN ACCORDANCE WITH THE INTERNAL LAWS (AS OPPOSED TO THE CONFLICT OF LAW PROVISIONS) AND DECISIONS OF THE STATE OF NEW YORK.

SECTION 7. Headings. Section headings in this Amendment are included herein for convenience of reference only and shall not constitute a part of this Amendment for any other purpose.

[Remainder of Page Intentionally Left Blank]

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed by their respective officers thereunto duly authorized as of the date first written above.

	New Transferring Affiliates:

		FRESENIUS KIDNEY CARE PITTSBURGH, LLC
		COLLEGE PARK DIALYSIS, LLC
		FRESENIUS MEDICAL CARE CAPITAL CITY, LLC

		(each a “New Transferring Affiliate”)

		By:
		Name:
		Title:

	Existing Transferring Affiliates:

	1.	APHERESIS CARE GROUP, INC.
	2.	BIO-MEDICAL APPLICATIONS MANAGEMENT COMPANY, INC.
	3.	BIO-MEDICAL APPLICATIONS OF ALABAMA, INC.
	4.	BIO-MEDICAL APPLICATIONS OF AMARILLO, INC.
	5.	BIO-MEDICAL APPLICATIONS OF ANACOSTIA, INC.
	6.	BIO-MEDICAL APPLICATIONS OF AQUADILLA, INC.
	7.	BIO-MEDICAL APPLICATIONS OF ARECIBO, INC.
	8.	BIO-MEDICAL APPLICATIONS OF ARKANSAS, INC.
	9.	BIO-MEDICAL APPLICATIONS OF BAYAMON, INC.
	10.	BIO-MEDICAL APPLICATIONS OF BLUE SPRINGS, INC.
	11.	BIO-MEDICAL APPLICATIONS OF CAGUAS, INC.
	12.	BIO-MEDICAL APPLICATIONS OF CALIFORNIA, INC.
	13.	BIO-MEDICAL APPLICATIONS OF CAMARILLO, INC.
	14.	BIO-MEDICAL APPLICATIONS OF CAROLINA, INC.
	15.	BIO-MEDICAL APPLICATIONS OF CLINTON, INC.
	16.	BIO-MEDICAL APPLICATIONS OF COLUMBIA HEIGHTS, INC.
	17.	BIO-MEDICAL APPLICATIONS OF CONNECTICUT, INC.
	18.	BIO-MEDICAL APPLICATIONS OF DELAWARE, INC.

Signature Page

Amendment No. 7 to Amended and Restated Transferring Affiliate Letter

	19.	BIO-MEDICAL APPLICATIONS OF DOVER, INC.
	20.	BIO-MEDICAL APPLICATIONS OF EUREKA, INC.
	21.	BIO-MEDICAL APPLICATIONS OF FAYETTEVILLE, INC.
	22.	BIO-MEDICAL APPLICATIONS OF FLORIDA, INC.
	23.	BIO-MEDICAL APPLICATIONS OF FREMONT, INC.
	24.	BIO-MEDICAL APPLICATIONS OF FRESNO, INC.
	25.	BIO-MEDICAL APPLICATIONS OF GEORGIA, INC.
	26.	BIO-MEDICAL APPLICATIONS OF GUAYAMA, INC.
	27.	BIO-MEDICAL APPLICATIONS OF HUMACAO, INC.
	28.	BIO-MEDICAL APPLICATIONS OF ILLINOIS, INC.
	29.	BIO-MEDICAL APPLICATIONS OF INDIANA, INC.
	30.	BIO-MEDICAL APPLICATIONS OF KANSAS, INC.
	31.	BIO-MEDICAL APPLICATIONS OF KENTUCKY, INC.
	32.	BIO-MEDICAL APPLICATIONS OF LOS GATOS, INC.
	33.	BIO-MEDICAL APPLICATIONS OF LOUISIANA, LLC
	34.	BIO-MEDICAL APPLICATIONS OF MAINE, INC.
	35.	BIO-MEDICAL APPLICATIONS OF MANCHESTER, INC.
	36.	BIO-MEDICAL APPLICATIONS OF MARYLAND, INC.
	37.	BIO-MEDICAL APPLICATIONS OF MASSACHUSETTS, INC.
	38.	BIO-MEDICAL APPLICATIONS OF MAYAGUEZ, INC.
	39.	BIO-MEDICAL APPLICATIONS OF MICHIGAN, INC.
	40.	BIO-MEDICAL APPLICATIONS OF MINNESOTA, INC.
	41.	BIO-MEDICAL APPLICATIONS OF MISSISSIPPI, INC.
	42.	BIO-MEDICAL APPLICATIONS OF MISSOURI, INC.
	43.	BIO-MEDICAL APPLICATIONS OF NEW HAMPSHIRE, INC.
	44.	BIO-MEDICAL APPLICATIONS OF NEW JERSEY, INC.
	45.	BIO-MEDICAL APPLICATIONS OF NEW MEXICO, INC.
	46.	BIO-MEDICAL APPLICATIONS OF NORTH CAROLINA, INC.
	47.	BIO-MEDICAL APPLICATIONS OF NORTHEAST D.C., INC.
	48.	BIO-MEDICAL APPLICATIONS OF OHIO, INC.
	49.	BIO-MEDICAL APPLICATIONS OF OKLAHOMA, INC.
	50.	BIO-MEDICAL APPLICATIONS OF PENNSYLVANIA, INC.
	51.	BIO-MEDICAL APPLICATIONS OF XXXXX, INC.

Signature Page

Amendment No. 7 to Amended and Restated Transferring Affiliate Letter

	52.	BIO-MEDICAL APPLICATIONS OF PUERTO RICO, INC.
	53.	BIO-MEDICAL APPLICATIONS OF RHODE ISLAND, INC.
	54.	BIO-MEDICAL APPLICATIONS OF RIO PIEDRAS, INC.
	55.	BIO-MEDICAL APPLICATIONS OF SAN GERMAN, INC.
	56.	BIO-MEDICAL APPLICATIONS OF SAN XXXX, INC.
	57.	BIO-MEDICAL APPLICATIONS OF SOUTH CAROLINA, INC.
	58.	BIO-MEDICAL APPLICATIONS OF SOUTHEAST WASHINGTON, INC.
	59.	BIO-MEDICAL APPLICATIONS OF TENNESSEE, INC.
	60.	BIO-MEDICAL APPLICATIONS OF TEXAS, INC.
	61.	BIO-MEDICAL APPLICATIONS OF THE DISTRICT OF COLUMBIA, INC.
	62.	BIO-MEDICAL APPLICATIONS OF VIRGINIA, INC.
	63.	BIO-MEDICAL APPLICATIONS OF WEST VIRGINIA, INC.
	64.	BIO-MEDICAL APPLICATIONS OF WISCONSIN, INC.
	65.	BIO-MEDICAL APPLICATIONS OF WYOMING, LLC
	66.	BREVARD COUNTY DIALYSIS, LLC
	67.	XXXXXXX COUNTY DIALYSIS, LLC
	68.	CLERMONT DIALYSIS CENTER, LLC
	69.	COLUMBUS AREA RENAL ALLIANCE, LLC
	70.	CONEJO VALLEY DIALYSIS, INC.
	71.	DIALYSIS AMERICA GEORGIA, LLC
	72.	DIALYSIS ASSOCIATES OF NORTHERN NEW JERSEY, L.L.C.
	73.	DIALYSIS CENTERS OF AMERICA - ILLINOIS, INC.
	74.	DIALYSIS MANAGEMENT CORPORATION
	75.	DIALYSIS SERVICES OF ATLANTA, INC.
	76.	DIALYSIS SERVICES OF CINCINNATI, INC.
	77.	DIALYSIS SPECIALISTS OF MARIETTA, LTD.
	78.	DIALYSIS SPECIALISTS OF TOPEKA, INC.
	79.	XXXXXXX COUNTY DIALYSIS, LLC
	80.	DU PAGE DIALYSIS LTD.
	81.	EVEREST HEALTHCARE HOLDINGS, INC.
	82.	EVEREST HEALTHCARE INDIANA, INC.
	83.	EVEREST HEALTHCARE OHIO, INC.
	84.	EVEREST HEALTHCARE RHODE ISLAND, INC.
	85.	EVEREST HEALTHCARE TEXAS, L.P.
	86.	FMS DELAWARE DIALYSIS, LLC
	87.	FMS PHILADELPHIA DIALYSIS, LLC

Signature Page

Amendment No. 7 to Amended and Restated Transferring Affiliate Letter

	88.	XXXXXXX DIALYSIS CLINIC, INC.
	89.	FORT XXXXX REGIONAL DIALYSIS CENTER, INC.
	90.	FOUR STATE REGIONAL DIALYSIS CENTER, INC.
	91.	FRESENIUS MANAGEMENT SERVICES, INC.
	92.	FRESENIUS MEDICAL CARE – SOUTH TEXAS KIDNEY, LLC
	93.	FRESENIUS MEDICAL CARE DIALYSIS SERVICES COLORADO, LLC
	94.	FRESENIUS MEDICAL CARE DIALYSIS SERVICES-OREGON, LLC
	95.	FRESENIUS MEDICAL CARE XXXXXXX HALL, LLC
	96.	FRESENIUS MEDICAL CARE HOLDINGS, INC.
	97.	FRESENIUS MEDICAL CARE OF ILLINOIS, LLC
	98.	FRESENIUS MEDICAL CARE OF MONTANA, LLC
	99.	FRESENIUS MEDICAL CARE VENTURES, LLC
	100.	FRESENIUS MEDICAL CARE WEST BEXAR, LLC
	101.	FRESENIUS MEDICAL CARE-OSUIM KIDNEY CENTERS, LLC
	102.	FRESENIUS USA MANUFACTURING, INC.
	103.	FRESENIUS USA MARKETING, INC.
	104.	FRESENIUS USA, INC.
	105.	GULF REGION MOBILE DIALYSIS, INC.
	106.	HAEMO-STAT, INC.
	107.	HAUPPAUGE DIALYSIS CENTER, LLC
	108.	XXXXX DIALYSIS CENTER, LLC
	109.	XXXXXX DIALYSIS CLINIC, LLC
	110.	HOME DIALYSIS OF MUHLENBERG COUNTY, INC.
	111.	HOMESTEAD ARTIFICIAL KIDNEY CENTER, INC.
	112.	INLAND NORTHWEST RENAL CARE GROUP, LLC
	113.	JEFFERSON COUNTY DIALYSIS, INC.
	114.	KDCO, INC.
	115.	KENTUCKY RENAL CARE GROUP, LLC
	116.	LITTLE ROCK DIALYSIS, INC.
	117.	MAUMEE DIALYSIS SERVICES, LLC
	118.	METRO DIALYSIS CENTER - NORMANDY, INC.
	119.	METRO DIALYSIS CENTER - NORTH, INC.
	120.	NATIONAL MEDICAL CARE, INC.
	121.	NATIONAL NEPHROLOGY ASSOCIATES OF TEXAS, L.P.
	122.	NEW YORK DIALYSIS SERVICES, INC.
	123.	NNA OF ALABAMA, INC.
	124.	NNA OF EAST ORANGE, L.L.C.
	125.	NNA OF GEORGIA, INC.
	126.	NNA OF XXXXXXXX, L.L.C.
	127.	NNA OF LOUISIANA, LLC
	128.	NNA OF OKLAHOMA, INC.

Signature Page

Amendment No. 7 to Amended and Restated Transferring Affiliate Letter

	129.	NNA OF OKLAHOMA, L.L.C.
	130.	NNA OF RHODE ISLAND, INC.
	131.	NNA OF TOLEDO, INC.
	132.	NNA-SAINT BARNABAS-LIVINGSTON, L.L.C.
	133.	NNA-SAINT BARNABAS, L.L.C.
	134.	NORTHEAST ALABAMA KIDNEY CLINIC, INC.
	135.	NORTHERN NEW JERSEY DIALYSIS, L.L.C.
	136.	NRA-ADA, OKLAHOMA, LLC
	137.	NRA-AUGUSTA, GEORGIA, LLC
	138.	NRA-BAMBERG, SOUTH CAROLINA, LLC
	139.	NRA-CROSSVILLE, TENNESSEE, LLC
	140.	NRA-FARMINGTON, MISSOURI, LLC
	141.	NRA-GEORGETOWN, KENTUCKY, LLC
	142.	NRA-HOGANSVILLE, GEORGIA, LLC
	143.	NRA-XXXXX XXXX, SOUTH CAROLINA, LLC
	144.	NRA-HOLLYWOOD, SOUTH CAROLINA, LLC
	145.	NRA-INPATIENT DIALYSIS, LLC
	146.	NRA-LAGRANGE, GEORGIA, LLC
	147.	NRA-MT. PLEASANT, SOUTH CAROLINA, LLC
	148.	NRA-NEW CASTLE, INDIANA, LLC
	149.	NRA-NEWNAN ACQUISITION, LLC
	150.	NRA-NORTH AUGUSTA, SOUTH CAROLINA, LLC
	151.	NRA-ORANGEBURG, SOUTH CAROLINA, LLC
	152.	NRA-PALMETTO, GEORGIA, LLC
	153.	NRA-PRINCETON, KENTUCKY, LLC
	154.	NRA-ROANOKE, ALABAMA, LLC
	155.	NRA-SOUTH CITY, MISSOURI, LLC
	156.	NRA-ST. LOUIS (HOME THERAPY CENTER), MISSOURI, LLC
	157.	NRA-ST. LOUIS, MISSOURI, LLC
	158.	NRA-TALLADEGA, ALABAMA, LLC
	159.	NRA-VALDOSTA (NORTH), GEORGIA, LLC
	160.	NRA-VALDOSTA, GEORGIA, LLC
	161.	NRA-VARNVILLE, SOUTH CAROLINA, LLC
	162.	NRA-WASHINGTON COUNTY, MISSOURI, LLC
	163.	NRA-WINCHESTER, INDIANA, LLC
	164.	PHYSICIANS DIALYSIS COMPANY, INC.
	165.	QUALICENTERS ALBANY, LTD.
	166.	QUALICENTERS BEND LLC
	167.	QUALICENTERS COOS BAY, LTD.
	168.	QUALICENTERS EUGENE-SPRINGFIELD, LTD.
	169.	QUALICENTERS INLAND NORTHWEST L.L.C.
	170.	QUALICENTERS PUEBLO LLC
	171.	QUALICENTERS SALEM LLC
	172.	QUALICENTERS SIOUX CITY, LLC
	173.	RAI CARE CENTERS OF ALABAMA, LLC

Signature Page

Amendment No. 7 to Amended and Restated Transferring Affiliate Letter

	174.	RAI CARE CENTERS OF FLORIDA I, LLC
	175.	RAI CARE CENTERS OF FLORIDA II, LLC
	176.	RAI CARE CENTERS OF GEORGIA I, LLC
	177.	RAI CARE CENTERS OF ILLINOIS I, LLC
	178.	RAI CARE CENTERS OF ILLINOIS II, LLC
	179.	RAI CARE CENTERS OF MARYLAND I, LLC
	180.	RAI CARE CENTERS OF MICHIGAN I, LLC
	181.	RAI CARE CENTERS OF MICHIGAN II, LLC
	182.	RAI CARE CENTERS OF NEBRASKA II, LLC
	183.	RAI CARE CENTERS OF NORTH CAROLINA II, LLC
	184.	RAI CARE CENTERS OF NORTHERN CALIFORNIA I, LLC
	185.	RAI CARE CENTERS OF NORTHERN CALIFORNIA II, LLC
	186.	RAI CARE CENTERS OF OAKLAND II, LLC
	187.	RAI CARE CENTERS OF SOUTH CAROLINA I, LLC
	188.	RAI CARE CENTERS OF SOUTHERN CALIFORNIA I, LLC
	189.	RAI CARE CENTERS OF SOUTHERN CALIFORNIA II, LLC
	190.	RAI CARE CENTERS OF VIRGINIA I, LLC
	191.	RCG BLOOMINGTON, LLC
	192.	RCG EAST TEXAS, LLP
	193.	RCG INDIANA, L.L.C.
	194.	RCG IRVING, LLP
	195.	RCG XXXXXX, LLC
	196.	RCG MEMPHIS EAST, LLC
	197.	RCG MISSISSIPPI, INC.
	198.	RCG PENSACOLA, LLC
	199.	RCG ROBSTOWN, LLP
	200.	RCG UNIVERSITY DIVISION, INC.
	201.	RENAL CARE GROUP, INC.
	202.	RENAL CARE GROUP ALASKA, INC.
	203.	RENAL CARE GROUP EAST, INC.
	204.	RENAL CARE GROUP MAPLEWOOD, LLC
	205.	RENAL CARE GROUP NORTHWEST, INC.
	206.	RENAL CARE GROUP OF THE MIDWEST, INC.
	207.	RENAL CARE GROUP OF THE OZARKS, LLC
	208.	RENAL CARE GROUP OF THE ROCKIES, LLC
	209.	RENAL CARE GROUP OF THE SOUTH, INC.
	210.	RENAL CARE GROUP OF THE SOUTHEAST, INC.
	211.	RENAL CARE GROUP SOUTH NEW MEXICO, LLC
	212.	RENAL CARE GROUP SOUTHWEST MICHIGAN, LLC
	213.	RENAL CARE GROUP SOUTHWEST, L.P.
	214.	RENAL CARE GROUP TERRE HAUTE, LLC

Signature Page

Amendment No. 7 to Amended and Restated Transferring Affiliate Letter

	215.	RENAL CARE GROUP TEXAS, INC.
	216.	RENAL CARE GROUP TOLEDO, LLC
	217.	RENAL CARE GROUP-HARLINGEN, L.P.
	218.	RENALPARTNERS, INC.
	219.	RENEX DIALYSIS CLINIC OF BLOOMFIELD, INC.
	220.	RENEX DIALYSIS CLINIC OF BRIDGETON, INC.
	221.	RENEX DIALYSIS CLINIC OF CREVE COEUR, INC.
	222.	RENEX DIALYSIS CLINIC OF MAPLEWOOD, INC.
	223.	RENEX DIALYSIS CLINIC OF ORANGE, INC.
	224.	RENEX DIALYSIS CLINIC OF PITTSBURGH, INC.
	225.	RENEX DIALYSIS CLINIC OF SOUTH GEORGIA, INC.
	226.	RENEX DIALYSIS CLINIC OF ST. LOUIS, INC.
	227.	RENEX DIALYSIS CLINIC OF TAMPA, INC.
	228.	RENEX DIALYSIS CLINIC OF UNIVERSITY CITY, INC.
	229.	RENEX DIALYSIS CLINIC OF WOODBURY, INC.
	230.	RENEX DIALYSIS FACILITIES, INC.
	231.	SAINT LOUIS RENAL CARE, LLC
	232.	SAN DIEGO DIALYSIS SERVICES, INC.
	233.	SANTA XXXXXXX COMMUNITY DIALYSIS CENTER, INC.
	234.	SMYRNA DIALYSIS CENTER, LLC
	235.	SSKG, INC.
	236.	ST. LOUIS REGIONAL DIALYSIS CENTER, INC.
	237.	STAT DIALYSIS CORPORATION
	238.	STONE MOUNTAIN DIALYSIS CENTER, LLC
	239.	STUTTGART DIALYSIS, LLC
	240.	TAPPAHANNOCK DIALYSIS CENTER, INC.
	241.	XXXXXXX DIALYSIS CENTER, L.L.C.
	242.	WARRENTON DIALYSIS FACILITY, INC.
	243.	WEST END DIALYSIS CENTER, INC.
	244.	WSKC DIALYSIS SERVICES, INC.

Signature Page

Amendment No. 7 to Amended and Restated Transferring Affiliate Letter

		(each an “Existing Transferring Affiliate”)

	By:
	Name:
	Title:

Signature Page

Amendment No. 7 to Amended and Restated Transferring Affiliate Letter

	FRESENIUS MEDICAL CARE VENTURES HOLDING COMPANY, INC.
	BIO-MEDICAL APPLICATIONS OF CAPITOL HILL, INC.
	BIO-MEDICAL APPLICATIONS OF OAKLAND, INC.
	BIO-MEDICAL APPLICATIONS OF UKIAH, INC.
	BIO-MEDICAL APPLICATIONS OF WOONSOCKET, INC.
	EVEREST HEALTHCARE TEXAS HOLDING CORP.
	FRESENIUS MEDICAL CARE APHERESIS SERVICES, LLC
	FRESENIUS MEDICAL CARE HEALTHCARE RECRUITMENT, LLC
	FRESENIUS MEDICAL CARE OF NEBRASKA, LLC
	FRESENIUS MEDICAL CARE PSO, LLC
	HOME DIALYSIS OF AMERICA, INC.
	NATIONAL NEPHROLOGY ASSOCIATES
	MANAGEMENT COMPANY OF TEXAS,
	NMC SERVICES, INC.
	NNA OF NEVADA, INC.
	NNA MANAGEMENT COMPANY OF KENTUCKY, INC.
	NNA MANAGEMENT COMPANY OF LOUISIANA, INC.
	NORTH XXXXXXX DIALYSIS CENTER, INC.
	NRA-BAY CITY, TEXAS, LLC
	QUALICENTERS, INC.
	RAI CARE CENTERS OF TENNESSEE, LLC
	RCG MEMPHIS, LLC
	RENAL CARE GROUP MICHIGAN, INC.
	RENAL CARE GROUP OHIO, INC.
	RENAL CARE GROUP SOUTHWEST HOLDINGS, INC.
	RENEX CORP.
	RENEX DIALYSIS CLINIC OF PHILADELPHIA, INC.
	XXXXXXX DIALYSIS, INC.

		(each, an “Existing Transferring Affiliate” and a “Terminated Transferring Affiliate”)

	By:
	Name:
	Title:

Signature Page

Amendment No. 7 to Amended and Restated Transferring Affiliate Letter

	NATIONAL MEDICAL CARE, INC.

	By:
	Name:
	Title:

Signature Page

Amendment No. 7 to Amended and Restated Transferring Affiliate Letter

Exhibit 5

to Amendment

EXHIBIT J

AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT

LIST OF TRANSFERRING AFFILIATES, CHIEF EXECUTIVE

OFFICES OF TRANSFERRING AFFILIATES AND TRADENAMES

SECTIONS 2.7(b), 3.1(i) and 3.1(k)(iv)

1	Apheresis Care Group, Inc.
2	Bio-Medical Applications Management Company, Inc.
3	Bio-Medical Applications of Alabama, Inc.
4	Bio-Medical Applications of Amarillo, Inc.
5	Bio-Medical Applications of Anacostia, Inc.
6	Bio-Medical Applications of Aquadilla, Inc.
7	Bio-Medical Applications of Arecibo, Inc.
8	Bio-Medical Applications of Arkansas, Inc.
9	Bio-Medical Applications of Bayamon, Inc.
10	Bio-Medical Applications of Blue Springs, Inc.
11	Bio-Medical Applications of Caguas, Inc.
12	Bio-Medical Applications of California, Inc.
13	Bio-Medical Applications of Camarillo, Inc.
14	Bio-Medical Applications of Carolina, Inc.
15	Bio-Medical Applications of Clinton, Inc.
16	Bio-Medical Applications of Columbia Heights, Inc.
17	Bio-Medical Applications of Connecticut, Inc.
18	Bio-Medical Applications of Delaware, Inc.
19	Bio-Medical Applications of Dover, Inc.
20	Bio-Medical Applications of Eureka, Inc.
21	Bio-Medical Applications of Fayetteville, Inc.
22	Bio-Medical Applications of Florida, Inc.
23	Bio-Medical Applications of Fremont, Inc.
24	Bio-Medical Applications of Fresno, Inc.
25	Bio-Medical Applications of Georgia, Inc.
26	Bio-Medical Applications of Guayama, Inc.
27	Bio-Medical Applications of Humacao, Inc.
28	Bio-Medical Applications of Illinois, Inc.
29	Bio-Medical Applications of Indiana, Inc.

J-1

30	Bio-Medical Applications of Kansas, Inc.
31	Bio-Medical Applications of Kentucky, Inc.
32	Bio-Medical Applications of Los Gatos, Inc.
33	Bio-Medical Applications of Louisiana, LLC
34	Bio-Medical Applications of Maine, Inc.
35	Bio-Medical Applications of Manchester, Inc.
36	Bio-Medical Applications of Maryland, Inc.
37	Bio-Medical Applications of Massachusetts, Inc.
38	Bio-Medical Applications of Mayaguez, Inc.
39	Bio-Medical Applications of Michigan, Inc.
40	Bio-Medical Applications of Minnesota, Inc.
41	Bio-Medical Applications of Mississippi, Inc.
42	Bio-Medical Applications of Missouri, Inc.
43	Bio-Medical Applications of New Hampshire, Inc.
44	Bio-Medical Applications of New Jersey, Inc.
45	Bio-Medical Applications of New Mexico, Inc.
46	Bio-Medical Applications of North Carolina, Inc.
47	Bio-Medical Applications of Northeast D.C., Inc.
48	Bio-Medical Applications of Ohio, Inc.
49	Bio-Medical Applications of Oklahoma, Inc.
50	Bio-Medical Applications of Pennsylvania, Inc.
51	Bio-Medical Applications of Ponce, Inc.
52	Bio-Medical Applications of Puerto Rico, Inc.
53	Bio-Medical Applications of Rhode Island, Inc.
54	Bio-Medical Applications of Rio Piedras, Inc.
55	Bio-Medical Applications of San German, Inc.
56	Bio-Medical Applications of San Xxxx, Inc.
57	Bio-Medical Applications of South Carolina, Inc.
58	Bio-Medical Applications of Southeast Washington, Inc.
59	Bio-Medical Applications of Tennessee, Inc.
60	Bio-Medical Applications of Texas, Inc.
61	Bio-Medical Applications of the District of Columbia, Inc.
62	Bio-Medical Applications of Virginia, Inc.
63	Bio-Medical Applications of West Virginia, Inc.
64	Bio-Medical Applications of Wisconsin, Inc.
65	Bio-Medical Applications of Wyoming, LLC
00	Xxxxxxx Xxxxxx Xxxxxxxx, XXX
00	Xxxxxxx Xxxxxx Dialysis, LLC
68	Clermont Dialysis Center, LLC
69	College Park Dialysis, LLC

X-0

00	Xxxxxxxx Xxxx Renal Alliance, LLC
71	Conejo Valley Dialysis, Inc.
72	Dialysis America Georgia, LLC
73	Dialysis Associates of Northern New Jersey, L.L.C.
74	Dialysis Centers of America - Illinois, Inc.
75	Dialysis Management Corporation
76	Dialysis Services of Atlanta, Inc.
77	Dialysis Services of Cincinnati, Inc.
78	Dialysis Specialists of Marietta, Ltd.
79	Dialysis Specialists of Topeka, Inc.
80	Xxxxxxx County Dialysis, LLC
81	Du Page Dialysis, Ltd.
82	Everest Healthcare Holdings, Inc.
83	Everest Healthcare Indiana, Inc.
84	Everest Healthcare Ohio, Inc.
85	Everest Healthcare Rhode Island, Inc.
86	Everest Healthcare Texas, L.P.
87	FMS Delaware Dialysis, LLC
88	FMS Philadelphia Dialysis, LLC
89	Xxxxxxx Dialysis Clinic, Inc.
90	Fort Xxxxx Regional Dialysis Center, Inc.
91	Four State Regional Dialysis Center, Inc.
92	Fresenius Kidney Care Pittsburgh, LLC
93	Fresenius Management Services, Inc.
00	Xxxxxxxxx Xxxxxxx Xxxx - Xxxxx Xxxxx Kidney, LLC
95	Fresenius Medical Care Capital City, LLC
96	Fresenius Medical Care Dialysis Services - Oregon, LLC
97	Fresenius Medical Care Dialysis Services Colorado LLC
98	Fresenius Medical Care Xxxxxxx Hall, LLC
99	Fresenius Medical Care Holdings, Inc.
100	Fresenius Medical Care of Illinois, LLC
101	Fresenius Medical Care of Montana, LLC
102	Fresenius Medical Care Ventures, LLC
103	Fresenius Medical Care West Bexar, LLC
104	Fresenius Medical Care-OSUIM Kidney Centers, LLC
105	Fresenius USA Manufacturing, Inc.
106	Fresenius USA Marketing, Inc.
107	Fresenius USA, Inc.
108	Gulf Region Mobile Dialysis, Inc.
109	Haemo-Stat, Inc.

J-3

110	Hauppauge Dialysis Center, LLC
111	Xxxxx Dialysis Center, LLC
112	Xxxxxx Dialysis Clinic, LLC
113	Home Dialysis of Muhlenberg County, Inc.
114	Homestead Artificial Kidney Center, Inc.
115	Inland Northwest Renal Care Group, LLC
116	Jefferson County Dialysis, Inc.
117	KDCO, Inc.
118	Kentucky Renal Care Group, LLC
000	Xxxxxx Xxxx Dialysis, Inc.
120	Maumee Dialysis Services, LLC
121	Metro Dialysis Center - Normandy, Inc.
122	Metro Dialysis Center - North, Inc.
123	National Medical Care, Inc.
124	National Nephrology Associates of Texas, L.P.
125	New York Dialysis Services, Inc.
126	NNA of Alabama, Inc.
127	NNA of East Orange, L.L.C.
128	NNA of Georgia, Inc.
129	NNA of Xxxxxxxx, L.L.C.
000	XXX xx Xxxxxxxxx, LLC
131	NNA of Oklahoma, Inc.
132	NNA of Oklahoma, L.L.C.
133	NNA of Rhode Island, Inc.
134	NNA of Toledo, Inc.
135	NNA-Saint Barnabas, L.L.C.
136	NNA-Saint Barnabas-Livingston, L.L.C.
000	Xxxxxxxxx Xxxxxxx Kidney Clinic, Inc.
138	Northern New Jersey Dialysis, L.L.C.
139	NRA-Ada, Oklahoma, LLC
000	XXX-Xxxxxxx, Xxxxxxx, LLC
000	XXX-Xxxxxxx, Xxxxx Xxxxxxxx, LLC
000	XXX-Xxxxxxxxxx, Xxxxxxxxx, LLC
000	XXX-Xxxxxxxxxx, Xxxxxxxx, LLC
000	XXX-Xxxxxxxxxx, Xxxxxxxx, LLC
000	XXX-Xxxxxxxxxxx, Xxxxxxx, LLC
000	XXX-Xxxxx Xxxx, Xxxxx Xxxxxxxx, LLC
000	XXX-Xxxxxxxxx, Xxxxx Xxxxxxxx, LLC
148	NRA-Inpatient Dialysis, LLC
000	XXX-XxXxxxxx, Xxxxxxx, LLC
000	XXX-Xx. Xxxxxxxx, Xxxxx Xxxxxxxx, LLC

J-4

000	XXX-Xxx Xxxxxx, Xxxxxxx, LLC
152	NRA-Newnan Acquisition, LLC
000	XXX-Xxxxx Xxxxxxx, Xxxxx Xxxxxxxx, LLC
000	XXX-Xxxxxxxxxx, Xxxxx Xxxxxxxx, LLC
000	XXX-Xxxxxxxx, Xxxxxxx, LLC
000	XXX-Xxxxxxxxx, Xxxxxxxx, LLC
000	XXX-Xxxxxxx, Xxxxxxx, LLC
000	XXX-Xxxxx Xxxx, Xxxxxxxx, LLC
000	XXX-Xx. Xxxxx (Xxxx Xxxxxxx Xxxxxx), Xxxxxxxx, LLC
000	XXX-Xx. Xxxxx, Xxxxxxxx, LLC
161	NRA-Talladega, Alabama, LLC
000	XXX-Xxxxxxxx (Xxxxx), Xxxxxxx, LLC
000	XXX-Xxxxxxxx, Xxxxxxx, LLC
000	XXX-Xxxxxxxxx, Xxxxx Xxxxxxxx, LLC
165	NRA-Washington County, Missouri, LLC
000	XXX-Xxxxxxxxxx, Xxxxxxx, LLC
167	Physicians Dialysis Company, Inc.
168	QualiCenters Albany, Ltd.
169	QualiCenters Bend, LLC
170	QualiCenters Coos Bay, Ltd.
171	QualiCenters Eugene-Springfield Ltd.
172	QualiCenters Inland Northwest LLC
173	QualiCenters Pueblo LLC
174	QualiCenters Salem, LLC
175	QualiCenters Sioux City LLC
000	XXX Xxxx Xxxxxxx xx Xxxxxxx, LLC
177	RAI Care Centers of Florida I, LLC
000	XXX Xxxx Xxxxxxx xx Xxxxxxx II, LLC
179	RAI Care Centers of Georgia I, LLC
000	XXX Xxxx Xxxxxxx xx Xxxxxxxx I, LLC
000	XXX Xxxx Xxxxxxx xx Xxxxxxxx II, LLC
000	XXX Xxxx Xxxxxxx xx Xxxxxxxx I, LLC
000	XXX Xxxx Xxxxxxx xx Xxxxxxxx I, LLC
000	XXX Xxxx Xxxxxxx xx Xxxxxxxx II, LLC
000	XXX Xxxx Xxxxxxx xx Xxxxxxxx II, LLC
000	XXX Xxxx Xxxxxxx xx Xxxxx Xxxxxxxx II, LLC
000	XXX Xxxx Xxxxxxx xx Xxxxxxxx Xxxxxxxxxx I, LLC
000	XXX Xxxx Xxxxxxx xx Xxxxxxxx Xxxxxxxxxx II, LLC
189	RAI Care Centers of Oakland II, LLC
000	XXX Xxxx Xxxxxxx xx Xxxxx Xxxxxxxx I, LLC
000	XXX Xxxx Xxxxxxx xx Xxxxxxxx Xxxxxxxxxx I, LLC

J-5

000	XXX Xxxx Xxxxxxx xx Xxxxxxxx Xxxxxxxxxx II, LLC
000	XXX Xxxx Xxxxxxx xx Xxxxxxxx I, LLC
194	RCG Bloomington, LLC
000	XXX Xxxx Xxxxx, LLP
196	RCG Indiana, L.L.C.
197	RCG Irving, LLP
198	RCG Xxxxxx, LLC
199	RCG Memphis East, LLC
200	RCG Mississippi, Inc.
201	RCG Pensacola, LLC
202	RCG Robstown, LLP
203	RCG University Division, Inc.
205	Renal Care Group, Inc.
205	Renal Care Group Alaska, Inc.
206	Renal Care Group East, Inc.
207	Renal Care Group Maplewood, LLC
208	Renal Care Group Northwest, Inc.
209	Renal Care Group of the Midwest, Inc.
210	Renal Care Group of the Ozarks, LLC
211	Renal Care Group of the Rockies, LLC
212	Renal Care Group of the South, Inc.
213	Renal Care Group of the Southeast, Inc.
214	Renal Care Group South New Mexico, LLC
215	Renal Care Group Southwest Michigan, LLC
216	Renal Care Group Southwest, L.P.
217	Renal Care Group Terre Haute, LLC
218	Renal Care Group Texas, Inc.
219	Renal Care Group Toledo, LLC
220	Renal Care Group-Harlingen, L.P.
222	RenalPartners, Inc.
222	Renex Dialysis Clinic of Bloomfield, Inc.
223	Renex Dialysis Clinic of Bridgeton, Inc.
224	Renex Dialysis Clinic of Creve Coeur, Inc.
225	Renex Dialysis Clinic of Maplewood, Inc.
226	Renex Dialysis Clinic of Orange, Inc.
227	Renex Dialysis Clinic of Pittsburgh, Inc.
000	Xxxxx Xxxxxxxx Xxxxxx xx Xxxxx Xxxxxxx, Inc.
229	Renex Dialysis Clinic of St. Louis, Inc.
230	Renex Dialysis Clinic of Tampa, Inc.
231	Renex Dialysis Clinic of University City, Inc.
232	Renex Dialysis Clinic of Woodbury, Inc.

J-6

233	Renex Dialysis Facilities, Inc.
234	Saint Louis Renal Care, LLC
235	San Diego Dialysis Services, Inc.
236	Santa Xxxxxxx Community Dialysis Center, Inc.
237	Smyrna Dialysis Center, LLC
238	SSKG, Inc.
239	St. Louis Regional Dialysis Center, Inc.
240	STAT Dialysis Corporation
241	Stone Mountain Dialysis Center, LLC
242	Stuttgart Dialysis, LLC
243	Tappahannock Dialysis Center, Inc.
244	Xxxxxxx Dialysis Center, L.L.C.
245	Warrenton Dialysis Facility, Inc.
000	Xxxx Xxx Dialysis Center, Inc.
247	WSKC Dialysis Services, Inc.

3.1(i) Place of Business: For each Transferring Affiliate, the principal place of business, chief executive office, and the offices where each Transferring Affiliate keeps substantially all its Records is 000 Xxxxxx Xxxxxx, Xxxxxxx, XX 00000 and such other locations listed in Exhibit G.

3.1(k)(iv)	Tradenames:	Renal Care Group	Fresenius Renal Technologies
		National Nephrology Associates	Fresenius Renal Therapies
		TruBlu Logistics (FUSA Mfg)	Fresenius Kidney Care
		Fresenius Renal Pharmaceuticals	Fresenius USA

	Merger:	On September 25, 2018, American Access Care of Bucks County, LLC, American Access Care of Pittsburgh, LLC, Gynesis Healthcare of Pennsylvania, Inc. and PD Solutions of Pennsylvania, merged into Physicians Dialysis Company, Inc.

		On September 25, 2018, Mercy Dialysis Center, Inc. merged into Bio-Medical Applications of Wisconsin, Inc.

J-7

Document Metadata

Table of Contents

AMENDMENT NO. 3 Dated as of December 20, 2018 to SECOND AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT Dated as of January 17, 2013

Document Metadata